CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 55 filers reported holding CITIUS PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,720 | -42.3% | 91,642 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $108,770 | +1.1% | 90,642 | -1.4% | 0.00% | 0.0% |
| Q1 2023 | $107,543 | +45.3% | 91,917 | -1.9% | 0.00% | 0.0% |
| Q4 2022 | $74,036 | -99.9% | 93,717 | -46.9% | 0.00% | 0.0% |
| Q3 2022 | $107,107,000 | +164680.0% | 176,344 | +148.0% | 0.00% | 0.0% |
| Q2 2022 | $65,000 | -9.7% | 71,102 | +77.1% | 0.00% | 0.0% |
| Q1 2022 | $72,000 | +7.5% | 40,137 | -7.2% | 0.00% | 0.0% |
| Q4 2021 | $67,000 | -19.3% | 43,237 | +5.6% | 0.00% | 0.0% |
| Q3 2021 | $83,000 | – | 40,958 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Inspire Advisors, LLC | 188,796 | $291,000 | 0.08% |
| Horst & Graben Wealth Management LLC | 75,722 | $117,000 | 0.03% |
| Alpine Global Management, LLC | 83,475 | $129,000 | 0.02% |
| Miller Investment Management, LP | 50,000 | $77,000 | 0.01% |
| SABBY MANAGEMENT, LLC | 30,863 | $48,000 | 0.01% |
| WILBANKS SMITH & THOMAS ASSET MANAGEMENT LLC | 49,075 | $76,000 | 0.00% |
| Alberta Investment Management Corp | 172,185 | $265,000 | 0.00% |
| Syverson Strege & Co | 2,145 | $3,000 | 0.00% |
| HighTower Advisors, LLC | 170,623 | $263,000 | 0.00% |
| HRT FINANCIAL LP | 90,871 | $139,000 | 0.00% |